Pharmacokinetics and outcome of high-dose melphalan followed by autologous stem cell transplantation in dialysis-dependent patients with multiple myeloma

High-dose melphalan followed by autologous stem cell transplantation (ASCT) remains the standard of care for fit patients with multiple myeloma (MM). However, individuals who are dependent on hemodialysis are frequently excluded from ASCT. Recommendations on chemotherapy dosing and hemodialysis sche...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Rabea Mecklenbrauck, Bernhard M.W. Schmidt, Heike Bähre, Annamaria Brioli, Arnold Ganser, Florian H. Heidel, Felicitas Thol
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2025-01-01
Reeks:	Leukemia Research Reports
Onderwerpen:	Multiple myeloma Autologous stem cell transplantation High-dose melphalan Hemodialysis
Online toegang:	http://www.sciencedirect.com/science/article/pii/S221304892500024X
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!